




版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
Type1diabetes
Nocure;therapyisinsulinforlife;physiologicglycaemiccontrolneverachievedIncidenceincreasingby~5%every5years;costs~£1billionofUKNHSbudgetExcessmorbidityandmortalityAnti-insulin:healthAnti-insulin:diseasePeakman/misc/diabetes/eisenbook.htmlType1diabetesNocure;thera1CD8T-cellHLAIInfiltratingCD4+,CD8+TcellsAnti-TcelltherapiesareeffectiveIsletcellautoantibodiesdiseaseCD4T-cellHLAIITCREpitopeCD4TregType1diabetesisTcellmediatedIsletautoantigenAPCPeakmanCD8HLAIInfiltratingCD4+,CD2TheImmuneSystemInnateRapidMicrobialDefenseAdaptiveImmuneSystemActivationAcquired(Adaptive)Long-livedMicrobialDefenseNeoplasmsurveillanceAutoimmunity,TransplantationRejection&AtopyBDCTheImmuneSystemInnateAcquire3TheInnateImmuneSystemAntimicrobialPeptides(e.g.,Defensins,Cathelicidins)Phagocytes(Macrophages,Neutrophils,Monocytes,DendriticCells)PatternRecognitionReceptorsAlternativeComplementSystemNKCellsB1BCells**AspectsofboththeinnateandadaptiveimmunesystemBDCTheInnateImmuneSystemBDC4SelectedPatternRecognitionReceptors:Toll-likeReceptorsTLR:SelectedLigands:RoleinImmunity:Localization:TLR1PGN,Zymosan,LipoproteinsAntifungal&AntibacterialDendriticCells,Macrophages,TCells,BCells,EpitheliumTLR2TLR6TLR4LPSAntibacterialTLR5FlagellinTLR11?TLR9CpGAntibacterial&AntiviralTLR3dsRNAAntiviralTLR7ssRNATLR8ssRNATLR10??SelectedPatternRecognitionR5SelectedPatternRecognitionReceptors:OtherFamiliesSelectedPatternRecognitionR6TheAdaptiveImmuneSystemCell-mediatedImmunity(Cytotoxicity)TcellsCD4+(Th1&Th2)CD8+(Tc1&Tc2)HumoralImmunity(Antibodyproduction)BCellsBDCTheAdaptiveImmuneSystemBDC7Th1andTh2CD4+TCellsTh1IL-12inducesdifferentiationCytokineProduction:
Interferon-
Interleukin-2IntracellularPathogensMacrophageActivationDelayedTypeHypersensitivityTh2IL-4inducesdifferentiationCytokineProduction:
Interleukin-4
Interleukin-5
Interleukin-13ExtracellularPathogensBCellactivation&IgEEosinophilresponsesImmediateTypeHypersensitivityBDCTh1andTh2CD4+TCellsTh1Th28HumanLeukocyteAntigenhumanMHCcell-surfaceproteinsimportantinselfvs.nonselfdistinctionpresentpeptideantigenstoTcellsCLASSI:A,B,CCLASSII:DR,DQ,DPHLAJ.NobleHumanLeukocyteAntigenCLASSI9TheHumanLeukocyteAntigenComplex(6p21.31)DPDQDRBCAClassII(1.1Mb)ClassIIIClassI(2.2Mb)ComplementandCytokinesClassI-likegenesandpseudogenesFrequentRecombination
RecombinationisRareTelomereCentromere
RecombinationisRare(0.7Mb)BDCTheHumanLeukocyteAntigenCo10a3b2a1a2a1a2b1b2Binds8-10mersExpressedonmostNucleatedcellsPresentsCytosolicProteinstoCD8+TcellsBinds13-25mersExpressedonAPCs,Macs,Bcells,activatedTcellsPresentsVesicularProteinstoCD4+TcellsClassI ClassIIHLAClassIandIIMoleculesHaveaDistinctStructureandFunctionBDCa3b2a1a2a1a2b1b2Binds8-10mers11AntigenAPCEndocytosisTCellReceptorPeptideMHCIICD4+
TcellTcellRecognitionofAntigenonanAPCAntigenAPCEndocytosisTCellRe12CD4+
TcellTCellReceptorPeptideLPSTLR4AntigenPresentingCell(APC)MHCII“Signal1”“Signal2”“Signal3”IL-1IL-6IL-12CD28B7IL-12ReceptorSignal1:SpecificitySignal2:ActivationSignal3:DifferentiationTcellActivationbyanActivatedAPCCD4+TCellReceptorPeptideLPS13AbsenceofSignal2ActivationClonalAnergyorDeletionTCRMHCAPCToleranceTCellTCRMHCAPCSignal1+Signal2B7TCellcytokinesCD28The2-SignalModelofLymphocyteActivationBDCAbsenceofSignal2ActivationC14ImmunologicaltoleranceDefinition:specificimmuneunresponsivenesstoanantigenthatisinducedbyexposureoflymphocytestothatantigen(tolerogenvsimmunogen)Significance:Allindividualsshouldbetolerantoftheirown antigens(self-tolerance);breakdown-->autoimmunityTheinductionoftolerancecouldbeexploitedtotreatautoimmunediseasesMechanismsoftolerancemustfirstbeunderstoodFathmanImmunologicaltoleranceDefinit15MechanismsofunresponsivenesstoselfantigensCentraltoleranceImmatureself-reactiveTlymphocytesthatrecognizeselfantigensinthethymusundergonegativeselection(deletion)PeripheraltoleranceMatureself-reactiveTlymphocytesthatescapecentraltoleranceandrecognizeselfantigensinperipheraltissuescanbeinactivated(anergy),killed(deletion)orregulated(suppressed)“Clonalignorance”Matureself-reactivelymphocytesdonotrespondtoselfantigens
innon-inflamedsettingsFathmanMechanismsofunresponsiveness16Requirementsforthedevelopment
ofanautoimmunediseaseNatureImmunology(9):759-761(2001)FathmanRequirementsforthedevelopme17ActivatedTH1CD4+TCellCD4+Cell(TH2)CD4+Cell(TH0)DR3,DR4,,DQ8/insulinpeptide
CD2Macrophage/dendriticcellFcR
IFN-gIL-12CD40LCD40a,b,TCRIL-1,TNF,LT,NO,PGE-2BCell?anti-insulin,GADabanti-MogIL-4ImmunopathophysiologyofDiabetes?AntibodymediatedinjuryDendriticcell/APCCD40LIL-4CD40LCD8+CTLFasLperforincelldeathisletcellsL.Chess2002ActivatedTH1CD4+TCellCD4+18DecioL.EizirikDecioL.Eizirik19DecioL.EizirikDecioL.Eizirik20Type1diabetes
Nocure;therapyisinsulinforlife;physiologicglycaemiccontrolneverachievedIncidenceincreasingby~5%every5years;costs~£1billionofUKNHSbudgetExcessmorbidityandmortalityAnti-insulin:healthAnti-insulin:diseasePeakman/misc/diabetes/eisenbook.htmlType1diabetesNocure;thera21CD8T-cellHLAIInfiltratingCD4+,CD8+TcellsAnti-TcelltherapiesareeffectiveIsletcellautoantibodiesdiseaseCD4T-cellHLAIITCREpitopeCD4TregType1diabetesisTcellmediatedIsletautoantigenAPCPeakmanCD8HLAIInfiltratingCD4+,CD22TheImmuneSystemInnateRapidMicrobialDefenseAdaptiveImmuneSystemActivationAcquired(Adaptive)Long-livedMicrobialDefenseNeoplasmsurveillanceAutoimmunity,TransplantationRejection&AtopyBDCTheImmuneSystemInnateAcquire23TheInnateImmuneSystemAntimicrobialPeptides(e.g.,Defensins,Cathelicidins)Phagocytes(Macrophages,Neutrophils,Monocytes,DendriticCells)PatternRecognitionReceptorsAlternativeComplementSystemNKCellsB1BCells**AspectsofboththeinnateandadaptiveimmunesystemBDCTheInnateImmuneSystemBDC24SelectedPatternRecognitionReceptors:Toll-likeReceptorsTLR:SelectedLigands:RoleinImmunity:Localization:TLR1PGN,Zymosan,LipoproteinsAntifungal&AntibacterialDendriticCells,Macrophages,TCells,BCells,EpitheliumTLR2TLR6TLR4LPSAntibacterialTLR5FlagellinTLR11?TLR9CpGAntibacterial&AntiviralTLR3dsRNAAntiviralTLR7ssRNATLR8ssRNATLR10??SelectedPatternRecognitionR25SelectedPatternRecognitionReceptors:OtherFamiliesSelectedPatternRecognitionR26TheAdaptiveImmuneSystemCell-mediatedImmunity(Cytotoxicity)TcellsCD4+(Th1&Th2)CD8+(Tc1&Tc2)HumoralImmunity(Antibodyproduction)BCellsBDCTheAdaptiveImmuneSystemBDC27Th1andTh2CD4+TCellsTh1IL-12inducesdifferentiationCytokineProduction:
Interferon-
Interleukin-2IntracellularPathogensMacrophageActivationDelayedTypeHypersensitivityTh2IL-4inducesdifferentiationCytokineProduction:
Interleukin-4
Interleukin-5
Interleukin-13ExtracellularPathogensBCellactivation&IgEEosinophilresponsesImmediateTypeHypersensitivityBDCTh1andTh2CD4+TCellsTh1Th228HumanLeukocyteAntigenhumanMHCcell-surfaceproteinsimportantinselfvs.nonselfdistinctionpresentpeptideantigenstoTcellsCLASSI:A,B,CCLASSII:DR,DQ,DPHLAJ.NobleHumanLeukocyteAntigenCLASSI29TheHumanLeukocyteAntigenComplex(6p21.31)DPDQDRBCAClassII(1.1Mb)ClassIIIClassI(2.2Mb)ComplementandCytokinesClassI-likegenesandpseudogenesFrequentRecombination
RecombinationisRareTelomereCentromere
RecombinationisRare(0.7Mb)BDCTheHumanLeukocyteAntigenCo30a3b2a1a2a1a2b1b2Binds8-10mersExpressedonmostNucleatedcellsPresentsCytosolicProteinstoCD8+TcellsBinds13-25mersExpressedonAPCs,Macs,Bcells,activatedTcellsPresentsVesicularProteinstoCD4+TcellsClassI ClassIIHLAClassIandIIMoleculesHaveaDistinctStructureandFunctionBDCa3b2a1a2a1a2b1b2Binds8-10mers31AntigenAPCEndocytosisTCellReceptorPeptideMHCIICD4+
TcellTcellRecognitionofAntigenonanAPCAntigenAPCEndocytosisTCellRe32CD4+
TcellTCellReceptorPeptideLPSTLR4AntigenPresentingCell(APC)MHCII“Signal1”“Signal2”“Signal3”IL-1IL-6IL-12CD28B7IL-12ReceptorSignal1:SpecificitySignal2:ActivationSignal3:DifferentiationTcellActivationbyanActivatedAPCCD4+TCellReceptorPeptideLPS33AbsenceofSignal2ActivationClonalAnergyorDeletionTCRMHCAPCToleranceTCellTCRMHCAPCSignal1+Signal2B7TCellcytokinesCD28The2-SignalModelofLymphocyteActivationBDCAbsenceofSignal2ActivationC34ImmunologicaltoleranceDefinition:specificimmuneunresponsivenesstoanantigenthatisinducedbyexposureoflymphocytestothatantigen(tolerogenvsimmunogen)Significance:Allindividualsshouldbetolerantoftheirown antigens(self-tolerance);breakdown-->autoimmunityTheinductionoftolerancecouldbeexploitedtotreatautoimmunediseasesMechanismsoftolerancemustfirstbeunderstoodFathmanImmunologicaltoleranceDefinit35MechanismsofunresponsivenesstoselfantigensCentraltoleranceImmatureself-reactiv
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2025园林景观建设合同示范文本
- 车展广告合作协议
- 2025涉外电子商务合同的法律规范
- 设计委托合同
- 公司员工入股协议书范本
- 在职培训进修合同书
- 2025设备租赁合同范本格式
- 2025园林景观设计劳务合同模板
- 村委委托砍树协议书
- 2025年03月天台县纪委县监委下属事业单位选聘工作人员笔试历年典型考题(历年真题考点)解题思路附带答案详解
- 2024年农艺师考试实务考核试题及答案
- 纵隔恶性肿瘤护理查房
- 山东省烟台市芝罘区(五四制)2022-2023学年七年级下学期期中考试英语试题及答案
- 2024年贵州省交通运输厅所属事业单位招聘考试真题
- 固定资产管理制度实施细则
- 统编版语文五年级下册习作《形形色色的人》精美课件
- 急诊科与住院部临床科室的患者交接制度与流程
- 2025届山西省晋中市高三下学期适应性训练考试(二模)英语试题+答案(原卷版+解析版)
- 2024北京朝阳区高二(下)期末英语试题和答案
- 2025年上半年安徽淮北市建投控股集团限公司招聘39人易考易错模拟试题(共500题)试卷后附参考答案
- 原料药行业趋势及市场前景分析报告
评论
0/150
提交评论